Objective Our previous study showed that insulin resistance (IR) was related to endometrial
hyperplasia as well as endometrial cancer. But the exact impact of IR on fertility-sparing …

Objective: Fertility-sparing treatment for young women with atypical endometrial hyperplasia
(AEH) and early endometrial cancer (EC) is a difficult challenge. Insulin resistance (IR) and …

Objective This study investigated the characteristics of progestin-insensitive endometrioid
endometrial cancer (EEC) and atypical endometrial hyperplasia (AEH) patients receiving …

Objectives: This study aimed to identify potential prognostic factors for patients with complex
atypical hyperplasia (CAH) or early-stage endometrial cancer (EC) who received progestin …

Objective: To evaluate the efficacy and prognosis of fertility-sparing treatment on
endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) patients with BMI≥ 30 …

Objectives The aim of the present study was to evaluate the impact of obesity on
reproductive and oncologic outcomes on the success of fertility-sparing management …

Purpose Obesity and diabetes (DM) are known to increase the risk of endometrial cancer
(EC). However, little is known about the prevalence of abnormal glucose metabolism and …

Objective To explore the relationship between metabolic abnormalities and DPE (disordered
proliferative endometrium), EH (endometrial hyperplasia) and type I EC (endometrial …

Objective To evaluate the various possible prognostic factors on the fertility-sparing
management of atypical hyperplasia and endometrial cancer; to generate survival curves to …

Objective The objective of this analysis was to evaluate weight changes associated with oral
progestin therapies versus the levonorgestrel-containing intrauterine device (LNG-IUD) in …